Skip to main content

Advertisement

Log in

Left ventricle assist devices and driveline’s infection incidence: a single-centre experience

  • Original Article
  • Artificial Heart (Clinical)
  • Published:
Journal of Artificial Organs Aims and scope Submit manuscript

Abstract

Different left ventricular assist devices (LVADs) are provided of different driveline exit sites: HeartWare HVAD presents abdominal power-cable-supply, while the Jarvik 2000 LVAD is powered by a retroauricular driveline. We analyzed 93 LVAD-implanted patients from January-2009 to October-2016 (41 HeartWare and 52 Jarvik 2000), hypothesizing a different incidence of infection, according to driveline exit site. The two populations were propensity matched for the demographic data and preoperative variables, and the outcomes were further analyzed. Nine driveline infections (DLIs) were in each LVAD group recorded (22% for HVAD and 17% for Jarvik 2000). The incidence of the complication was similar between groups (p = 0.97), even during time (p = 0.27 within 6 months and p = 0.16 over 6 months of support). Age at implant (p = 0.01), revision for bleeding (p = 0.05), days of postoperative intubation (p = 0.002), and ICU stay (p < 0.001), as well as days on device (p < 0.001) were identified as risk factors for DLIs. The type of device and the driveline exit site were not statistically co-related to infections. Similar infection-freedom survival was identified (p = 0.87). Younger age at implant, revision for bleeding, prolonged mechanical ventilation, delayed rehabilitation, as well as long time LVAD support were identified as risk factors for exit site DLIs. Despite similar incidence of DLIs, the different management and care of the retroauricular exit site makes it more appropriate and comfortable in long-term support.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Kormos RL, Borovetz HS, Armitage JM, Hardesty RL, Marrone GC, Griffith BP. Evolving experience with mechanical circulatory support. Ann Surg. 1991;214:471–6 (discussion 476-7).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Petri WA Jr. Infections in heart transplant recipients. Clin Infect Dis. 1994;18:141–6 (Quiz 147-8).

    Article  PubMed  Google Scholar 

  3. Jarvik R, Westaby S, Katsumata T, Pigott D, Evans RD. LVAD power delivery. A percutaneous approach to avoid infection. Ann Thorac Surg. 1998;65:470–3.

    Article  CAS  PubMed  Google Scholar 

  4. Siegenthaler MP, Martin J, Pernice K, Doenst T, Sorg S, Trummer G, Friesewinkel O, Beyersdorf F. The Jarvik 2000 is associated with less infections than the HeartMate left ventricular assist device. Eur J Cardiothorac Surg. 2003;23:748–55.

    Article  CAS  PubMed  Google Scholar 

  5. Bottio T, Bejko J, Gallo M, Bortolussi G, Gerosa G. Less invasive implantation of HeartWare left ventricular assist device. Multimed Man Cardiothorac Surg. 2014. doi:10.1093/mmcts/mmu008.

  6. Bejko J, Guariento A, Bortolussi G, Tarzia V, Gerosa G, Bottio T. Minimally invasive surgical Jarvik 2000 off-pump implantation. Multimed Man Cardiothorac Surg. 2015. doi:10.1093/mmcts/mmv020.

  7. Bottio T, Bejko J, Guariento A, Tarzia V, Pittarello D, Gerosa G. Bilateral mini-thoracotomy off-pump Jarvik 2000 implantation in regional asymmetric paravertebral analgesia. J Cardiovasc Med (Hagerstown). 2016;17:160–4.

    Article  Google Scholar 

  8. Bortolussi G, Lika A, Bejko J, Gallo M, Tarzia V, Gerosa G, Bottio T. Left ventricular assist device end-to-end connection to the left subclavian artery: an alternative technique. Ann Thorac Surg. 2015;100:e93–5.

    Article  PubMed  Google Scholar 

  9. Gallo M, Bortolussi G, Bejko J, Tarzia V, Gerosa G, Bottio T. How to remove the retroauricular driveline in the Jarvik 2000 after heart transplantation. Int J Artif Organs. 2016;39:45–7.

    Article  PubMed  Google Scholar 

  10. Bejko J, Tarzia V, Gerosa G, Bottio T. Use of the Jarvik 2000 to facilitate left ventricular assist device placement in challenging apex anatomy. J Heart Lung Transpl. 2016;35:1049–51.

    Article  Google Scholar 

  11. Gerosa G, Gallo M, Tarzia V, Di Gregorio G, Zanella F, Bottio T. Less invasive surgical and perfusion technique for implantation of the Jarvik 2000 left ventricular assist device. Ann Thorac Surg. 2013;96:712–4.

    Article  PubMed  Google Scholar 

  12. Hannan MM, Husain S, Mattner F, Danziger-Isakov L, Drew RJ, Corey GR, Schueler S, Holman WL, Lawler LP, Gordon SM, Mahon NG, Herre JM, Gould K, Montoya JG, Padera RF, Kormos RL, Conte JV, Mooney ML. International Society for Heart and Lung Transplantation. Working formulation for the standardization of definitions of infections in patients using ventricular assist devices. J Heart Lung Transpl. 2011;30:375–84.

    Article  Google Scholar 

  13. Sharma V, Deo SV, Stulak JM, Durham LA 3rd, Daly RC, Park SJ, Baddour LM, Mehra K, Joyce LD. Driveline infections in left ventricular assist devices: implications for destination therapy. Ann Thorac Surg. 2012;94:1381–6.

    Article  PubMed  Google Scholar 

  14. Pereda D, Conte JV. Left ventricular assist device driveline infections. Cardiol Clin. 2011;29:515–27.

    Article  PubMed  Google Scholar 

  15. Akhter SA, Badami A, Murray M, Kohmoto T, Lozonschi L, Osaki S, Lushaj EB. Hospital readmissions after continuous-flow left ventricular assist device implantation: incidence, causes, and cost analysis. Ann Thorac Surg. 2015;100:884–9.

    Article  PubMed  Google Scholar 

  16. Centofanti P, Attisani M, Bosco GF, Khayat A, La Torre M, Baronetto A, Boffini M, Rinaldi M. Successful replacement of a detached pedestal during support with Jarvik 2000. Int J Artif Organs. 2012;35:152–5.

    Article  PubMed  Google Scholar 

  17. Zierer A, Melby SJ, Voeller RK, Guthrie TJ, Ewald GA, Shelton K, Pasque MK, Moon MR, Damiano RJ Jr, Moazami N. Late-onset driveline infections: the Achilles’ heel of prolonged left ventricular assist device support. Ann Thorac Surg. 2007;84:515–20.

    Article  PubMed  Google Scholar 

  18. Califano S, Pagani FD, Malani PN. Left ventricular assist device-associated infections. Infect Dis Clin N Am. 2012;26:77–87.

    Article  Google Scholar 

  19. Meszaros K, Fuehrer U, Grogg S, Sodeck G, Czerny M, Marschall J, Carrel T. Risk factors for sternal wound infection after open heart operations vary according to type of operation. Ann Thorac Surg. 2016;101:1418–25.

    Article  PubMed  Google Scholar 

  20. Goldstein DJ, Naftel D, Holman W, Bellumkonda L, Pamboukian SV, Pagani FD, Kirklin J. Continuous-flow devices and percutaneous site infections: clinical outcomes. J Heart Lung Transpl. 2012;31:1151–7.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jonida Bejko.

Ethics declarations

Conflict of interest

The authors have no disclosures to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bejko, J., Toto, F., Gregori, D. et al. Left ventricle assist devices and driveline’s infection incidence: a single-centre experience. J Artif Organs 21, 52–60 (2018). https://doi.org/10.1007/s10047-017-0997-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10047-017-0997-y

Keywords

Navigation